Form 4: Alignment Healthcare CEO John Kao Sells 90,000 Shares

Alignment Healthcare's CEO, John Kao, sold 90,000 shares of common stock at an average price of $14.2256 on February 11, 2025, according to a Form 4 filing.

Summary

• John Kao, the CEO of Alignment Healthcare, sold 90,000 shares of common stock on February 11, 2025.
• The shares were sold at a weighted-average price of $14.2256, with individual prices ranging from $14.06 to $14.375.
• Following the transaction, Mr. Kao directly owns 2,745,253 shares and indirectly owns 2,183,100 shares through the JEK Trust, dated February 8, 2021, of which he is the trustee.
• The sale was executed under a Rule 10b5-1 trading plan adopted on March 14, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment towards the company's prospects.

Industry Context

Executive stock sales are a common occurrence and are often related to personal financial planning. It's important to consider the overall context of insider transactions, including the frequency and size of the trades, as well as the company's performance and outlook.

Stakeholder Impact

• The stock sale could have a minor impact on shareholder sentiment, depending on how it's perceived by the market.

Key Dates

Keywords

Form 4, share sale, John Kao, Alignment Healthcare, ALHC, CEO, stock transaction, Rule 10b5-1 plan